Ferreira de Oliveira, J.M.P.; Almeida, J.F.D.; Martins, M.; Proença, C.; Oliveira, H.; Fernandes, E.; Santos, C.
3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma. Pharmaceuticals 2021, 14, 640.
https://doi.org/10.3390/ph14070640
AMA Style
Ferreira de Oliveira JMP, Almeida JFD, Martins M, Proença C, Oliveira H, Fernandes E, Santos C.
3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma. Pharmaceuticals. 2021; 14(7):640.
https://doi.org/10.3390/ph14070640
Chicago/Turabian Style
Ferreira de Oliveira, José Miguel P., Joana Filipa D. Almeida, Maria Martins, Carina Proença, Helena Oliveira, Eduarda Fernandes, and Conceição Santos.
2021. "3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma" Pharmaceuticals 14, no. 7: 640.
https://doi.org/10.3390/ph14070640
APA Style
Ferreira de Oliveira, J. M. P., Almeida, J. F. D., Martins, M., Proença, C., Oliveira, H., Fernandes, E., & Santos, C.
(2021). 3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma. Pharmaceuticals, 14(7), 640.
https://doi.org/10.3390/ph14070640